Cargando…
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer
The prostate is surrounded by periprostatic adipose tissue (PPAT), the thickness of which has been associated with more aggressive prostate cancer (PCa). There are limited data regarding the functional characteristics of PPAT, how it compares to subcutaneous adipose tissue (SAT), and whether in a se...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352157/ https://www.ncbi.nlm.nih.gov/pubmed/32481537 http://dx.doi.org/10.3390/cancers12061385 |
_version_ | 1783557572038492160 |
---|---|
author | Miladinovic, Dushan Cusick, Thomas Mahon, Kate L. Haynes, Anne-Maree Cortie, Colin H. Meyer, Barbara J. Stricker, Phillip D. Wittert, Gary A. Butler, Lisa M. Horvath, Lisa G. Hoy, Andrew J. |
author_facet | Miladinovic, Dushan Cusick, Thomas Mahon, Kate L. Haynes, Anne-Maree Cortie, Colin H. Meyer, Barbara J. Stricker, Phillip D. Wittert, Gary A. Butler, Lisa M. Horvath, Lisa G. Hoy, Andrew J. |
author_sort | Miladinovic, Dushan |
collection | PubMed |
description | The prostate is surrounded by periprostatic adipose tissue (PPAT), the thickness of which has been associated with more aggressive prostate cancer (PCa). There are limited data regarding the functional characteristics of PPAT, how it compares to subcutaneous adipose tissue (SAT), and whether in a setting of localized PCa, these traits are altered by obesity or disease aggressiveness. PPAT and SAT were collected from 60 men (age: 42–78 years, BMI: 21.3–35.6 kg/m(2)) undergoing total prostatectomy for PCa. Compared to SAT, adipocytes in PPAT were smaller, had the same basal rates of fatty acid release (lipolysis) yet released less polyunsaturated fatty acid species, and were more sensitive to isoproterenol-stimulated lipolysis. Basal lipolysis of PPAT was increased in men diagnosed with less aggressive PCa (Gleason score (GS) ≤ 3 + 4) compared to men with more aggressive PCa (GS ≥ 4 + 3) but no other measured adipocyte parameters related to PCa aggressiveness. Likewise, there was no difference in PPAT lipid biology between lean and obese men. In conclusion, lipid biological features of PPAT do differ from SAT; however, we did not observe any meaningful difference in ex vivo PPAT biology that is associated with PCa aggressiveness or obesity. As such, our findings do not support a relationship between altered PCa behavior in obese men and the metabolic reprogramming of PPAT. |
format | Online Article Text |
id | pubmed-7352157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73521572020-07-15 Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer Miladinovic, Dushan Cusick, Thomas Mahon, Kate L. Haynes, Anne-Maree Cortie, Colin H. Meyer, Barbara J. Stricker, Phillip D. Wittert, Gary A. Butler, Lisa M. Horvath, Lisa G. Hoy, Andrew J. Cancers (Basel) Article The prostate is surrounded by periprostatic adipose tissue (PPAT), the thickness of which has been associated with more aggressive prostate cancer (PCa). There are limited data regarding the functional characteristics of PPAT, how it compares to subcutaneous adipose tissue (SAT), and whether in a setting of localized PCa, these traits are altered by obesity or disease aggressiveness. PPAT and SAT were collected from 60 men (age: 42–78 years, BMI: 21.3–35.6 kg/m(2)) undergoing total prostatectomy for PCa. Compared to SAT, adipocytes in PPAT were smaller, had the same basal rates of fatty acid release (lipolysis) yet released less polyunsaturated fatty acid species, and were more sensitive to isoproterenol-stimulated lipolysis. Basal lipolysis of PPAT was increased in men diagnosed with less aggressive PCa (Gleason score (GS) ≤ 3 + 4) compared to men with more aggressive PCa (GS ≥ 4 + 3) but no other measured adipocyte parameters related to PCa aggressiveness. Likewise, there was no difference in PPAT lipid biology between lean and obese men. In conclusion, lipid biological features of PPAT do differ from SAT; however, we did not observe any meaningful difference in ex vivo PPAT biology that is associated with PCa aggressiveness or obesity. As such, our findings do not support a relationship between altered PCa behavior in obese men and the metabolic reprogramming of PPAT. MDPI 2020-05-28 /pmc/articles/PMC7352157/ /pubmed/32481537 http://dx.doi.org/10.3390/cancers12061385 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Miladinovic, Dushan Cusick, Thomas Mahon, Kate L. Haynes, Anne-Maree Cortie, Colin H. Meyer, Barbara J. Stricker, Phillip D. Wittert, Gary A. Butler, Lisa M. Horvath, Lisa G. Hoy, Andrew J. Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer |
title | Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer |
title_full | Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer |
title_fullStr | Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer |
title_full_unstemmed | Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer |
title_short | Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer |
title_sort | assessment of periprostatic and subcutaneous adipose tissue lipolysis and adipocyte size from men with localized prostate cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352157/ https://www.ncbi.nlm.nih.gov/pubmed/32481537 http://dx.doi.org/10.3390/cancers12061385 |
work_keys_str_mv | AT miladinovicdushan assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT cusickthomas assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT mahonkatel assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT haynesannemaree assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT cortiecolinh assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT meyerbarbaraj assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT strickerphillipd assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT wittertgarya assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT butlerlisam assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT horvathlisag assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer AT hoyandrewj assessmentofperiprostaticandsubcutaneousadiposetissuelipolysisandadipocytesizefrommenwithlocalizedprostatecancer |